Respiratory distress syndrome mortality in the United States, 1987 to 1995

Journal of Perinatology

Volumn 20, Issue 7, 2000, Pages 414-420

  Malloy, Michael H ^a   Freeman, Daniel H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ETHNIC GROUP; FEMALE; HUMAN; INFANT; INFANT MORTALITY; MALE; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; SEX DIFFERENCE; STATISTICS; UNITED STATES;

ETHNIC GROUPS; FEMALE; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MALE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SEX FACTORS; UNITED STATES;

EID: 0034305262     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200420     Document Type: Article

References (29)

1. Horbar JD, Wright EC, Onstad L, et al. Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. Pediatrics 1993;92:191-196.
2. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med 1994;330:1476-1480.
3. Singh GK, Yu SM. Infant mortality in the United States: trends, differentials, and projections, 1950 through 2010. Am J Public Health 1995;85:957-964.
4. Hamvas A, Wise PH, Yan RK, et al. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites. N Engl J Med 1996;334:1635-1640.
5. Schoendorf KC, Kiely JL Birth weight and age-specific analysis of the 1990 US infant mortality drop. Arch Pediatr Adolesc Med 1997;151:129-134.
6. Malloy MH, Hartford RB, Kleinman JC. Trends in mortality caused by respiratory distress syndrome in the United States, 1969-83. Am J Public Health 1987;77:1511-1514.
7. Lee KS, Khoshnood B, Wall SN, Chang YP, Hsieh HL, Singh JK. Trend in mortality from respiratory distress syndrome in the United States, 1970-1995. J Pediatr 1999;134:434-440.
8. SAS Institute Inc. SAS User's Guide: Statistics, Version 5 Edition. Cary, NC: SAS Institute Inc., 1985.
9. Kleinbaum DG, Kupper LL, Morgenstern H. Modeling: theoretical considerations. In: Epidemiologic Research: Principles and Quantitative Methods. Lifetime Learning Publ, Belmont CA. 1982:414-446.
10. Carver JD, McDermott RJ, Jacobson IDJ, Sherin KM, Kanarek K, Pimentel B, Tan LH. Infant mortality statistics do not adequately reflect the impact of short gestation. Pediatrics 1993;92:229-232.
11. Barton L, Hodgman JE, Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999;103:446-451.
12. NIH Consensus Development Panel. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-418.
13. Guyer B, MacDorman MF, Martin JA, Peters KD, Strobino DM. Annual summary of vital statistics - 1997. Pediatrics 1998;102:1333-1349.
14. Malloy MH, Freeman DJ. Birth weight and gestational age specific sudden infant death syndrome mortality: United States 1991 vs. 1995. Pediatr Res 1999;45:249A
15. Fjuikura T, Froehlich IA. The influence of race and other factors on pulmonary hyaline membranes. Am J Obstet Gynecol 1966;95:572-578.
16. Olowe SA, Akinkugbe A. Amniotic fluid lecithin/sphingomyelin ratio: comparison between an African and a North American community. Pediatrics 1978;62:38-41.
17. Ross S, Naeye RL Racial and environmental influences on fetal lung maturation. Pediatrics 1981;68:790-795.
18. Hulsey TC, Alexander GR, Robillard PY, Annibale DJ, Keenan A. Hyaline membrane disease: the role of ethnicity and maternal risk characteristics. Am J Obstet Gynecol 1993;168:572-576.
19. Richardson DK, Torday JS. Racial differences in predictive value of the lecithin/sphingomyelin ration. Am J Obstet Gynecol 1994;170:1273-1278.
20. Wilcox A, Russell I. Why small black infants have a lower mortality rate than small white infants: the case for population-specific standards for birth weight. J Pediatr 1990;116:7-10.
21. Wise PH, Pursley DM. Infant mortality as a social mirror. N Engl J Med 1992;326:1558-1559.
22. Osborne NG, Feit MD. The use of race in medical research. JAMA 1992;267:275-279.
23. Hogue CJR, Hargraves MA. Class, race, and infant mortality in the United States. Am J Public Health 1993;83:9-12.
24. Naeye RL, Burt L, Wright DL, Blanc WA, Tatter D. Neonatal mortality, the male disadvantage. Pediatrics 1971;48:902-906.
25. Farrell PM, Wood RE. Epidemiology of hyaline membrane disease in the United States: analysis of national mortality statistics. Pediatrics 1976;58:167-176.
26. Perelman RH, Farrell PM. Analysis of causes of neonatal death in the United States with specific emphasis on fatal hyaline membrane disease. Pediatrics 1982;70:570-575.
27. Perelman RH, Palta M, Kirby R, Farrell PM. Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics 1986;78:238-244.
28. Ballard PL, Ballard RA, Granberg JP, Sniderman S, Gluckman PD, Kaplan S, Grumbach ALM. Fetal sex and prenatal betamethasone therapy. J Pediatr 1980;97:451-454.
29. Morrison JC, Korones SB, Curet LB, et al. Influence of infant gender on respiratory distress syndrome occurring after maternal treatment with dexamethasone. J Perinatol 1985;5:2-5.